Expression of RARRES2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RARRES2 is validated prognostic, high expression is unfavorable in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 33.53

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

152.1

Number of samples

141

Samples

Sample	Description	TPM
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	1867.6
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	1039.5
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	838.8
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	811.6
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	799.2
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	626.6
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	486.1
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	485.7
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	457.6
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	385.5
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	358.4
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	335.1
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	334.0
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	327.9
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	305.9
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	295.9
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	281.2
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	276.5
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	274.8
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	269.6
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	266.2
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	238.7
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	224.8
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	218.7
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	217.7
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	215.8
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	212.1
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	201.2
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	199.6
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	193.9
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	192.8
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	190.1
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	181.4
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	181.2
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	180.8
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	179.4
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	178.0
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	175.3
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	174.5
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	173.5
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	165.3
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	163.7
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	144.0
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	139.1
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	138.5
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	138.2
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	136.8
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	132.3
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	125.5
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	124.7
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	122.0
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	121.6
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	121.6
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	119.2
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	116.8
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	116.3
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	115.6
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	115.5
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	114.1
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	112.0
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	109.4
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	108.2
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	107.4
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	106.6
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	103.8
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	103.7
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	102.6
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	100.3
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	98.2
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	94.5
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	93.5
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	93.0
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	91.9
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	89.4
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	86.9
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	84.7
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	83.9
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	82.9
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	82.3
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	81.6
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	76.3
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	71.7
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	70.8
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	70.8
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	68.7
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	65.4
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	64.1
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	63.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	63.7
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	61.1
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	59.0
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	58.6
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	55.6
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	54.9
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	54.9
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	53.4
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	52.7
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	52.1
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	49.7
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	49.7
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	49.1
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	46.2
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	42.3
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	41.4
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	39.9
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	37.2
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	36.7
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	34.4
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	34.1
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	33.0
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	32.9
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	32.9
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	32.9
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	32.5
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	29.9
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	29.1
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	29.1
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	27.0
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	26.1
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	25.7
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	22.9
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	21.2
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	17.1
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	13.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	12.1
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	11.5
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	10.9
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	10.8
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	9.5
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	9.3
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	8.5
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	8.5
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	7.1
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	6.3
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	6.2
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	5.9
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	5.1
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	4.0
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	3.9
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	3.0
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	2.8
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RARRES2 is validated prognostic, high expression is unfavorable in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 0.91

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

4.4

Number of samples

Samples

Sample	Description	TPM
AK185	N, NA, stage:NA, alive, 330 days	49.4
AK236	N, NA, stage:NA, dead, 360 days	13.4
AK055	N, NA, stage:NA, dead, 240 days	12.9
AK139	N, NA, stage:NA, dead, 270 days	12.2
AK006	N, NA, stage:NA, dead, 360 days	11.1
AK098	N, NA, stage:NA, dead, 660 days	10.4
AK051	N, NA, stage:NA, dead, 360 days	10.2
AK074	N, NA, stage:NA, alive, 300 days	9.7
AK188	N, NA, stage:NA, alive, 420 days	9.1
AK218	N, NA, stage:NA, dead, 180 days	8.4
AK088	N, NA, stage:NA, dead, 360 days	8.4
AK072	N, NA, stage:NA, dead, 150 days	7.4
AK183	N, NA, stage:NA, alive, 360 days	6.1
AK002	N, NA, stage:NA, dead, 570 days	5.6
AK153	N, NA, stage:NA, dead, 240 days	5.5
AK005	N, NA, stage:NA, dead, 240 days	5.4
AK049	N, NA, stage:NA, dead, 180 days	5.4
AK173	N, NA, stage:NA, dead, 180 days	5.1
AK133	N, NA, stage:NA, dead, 360 days	4.3
AK081	N, NA, stage:NA, dead, 180 days	4.2
AK071	N, NA, stage:NA, dead, 540 days	4.2
AK053	N, NA, stage:NA, dead, 300 days	4.1
AK091	N, NA, stage:NA, dead, 210 days	3.9
AK195	N, NA, stage:NA, dead, 390 days	3.6
AK079	N, NA, stage:NA, dead, 210 days	3.1
AK156	N, NA, stage:NA, dead, 330 days	2.9
AK134	N, NA, stage:NA, dead, 360 days	2.9
AK178	N, NA, stage:NA, dead, 240 days	2.9
AK030	N, NA, stage:NA, dead, 120 days	2.6
AK089	N, NA, stage:NA, dead, 330 days	2.4
AK100	N, NA, stage:NA, alive, 960 days	2.2
AK158	N, NA, stage:NA, dead, 360 days	2.0
AK035	N, NA, stage:NA, dead, 210 days	1.9
AK003	N, NA, stage:NA, dead, 600 days	1.8
AK099	N, NA, stage:NA, dead, 420 days	1.7
AK227	N, NA, stage:NA, alive, 300 days	1.6
AK117	N, NA, stage:NA, dead, 210 days	1.2
AK216	N, NA, stage:NA, dead, 360 days	1.0
AK167	N, NA, stage:NA, dead, 180 days	1.0
AK123	N, NA, stage:NA, dead, 180 days	0.9
AK043	N, NA, stage:NA, alive, 660 days	0.9
AK149	N, NA, stage:NA, dead, 420 days	0.9
AK165	N, NA, stage:NA, alive, 360 days	0.6
AK015	N, NA, stage:NA, alive, 720 days	0.5
AK226	N, NA, stage:NA, dead, 360 days	0.4
AK231	N, NA, stage:NA, dead, 240 days	0.4
AK076	N, NA, stage:NA, alive, 660 days	0.4
AK142	N, NA, stage:NA, alive, 90 days	0.3
AK199	N, NA, stage:NA, alive, 1860 days	0.2
AK205	N, NA, stage:NA, dead, 120 days	0.2
AK068	N, NA, stage:NA, alive, 360 days	0.1
AK085	N, NA, stage:NA, alive, 660 days	0.1
AK124	N, NA, stage:NA, alive, 1920 days	0.1
AK102	N, NA, stage:NA, alive, 1740 days	0.1
AK066	N, NA, stage:NA, alive, 960 days	0.1
AK213	N, NA, stage:NA, alive, 2010 days	0.1
AK103	N, NA, stage:NA, alive, 1320 days	0.1
AK041	N, NA, stage:NA, alive, 810 days	0.0
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0217430008	Tumor	1.9
CPT0201710003	Tumor	1.9
CPT0123530003	Tumor	1.5
CPT0127420003	Tumor	1.2
CPT0093450003	Tumor	1.0
CPT0228220003	Tumor	1.0
CPT0079790003	Tumor	0.9
CPT0206670004	Tumor	0.9
CPT0206230003	Tumor	0.8
CPT0087950003	Tumor	0.7
CPT0092440003	Tumor	0.7
CPT0224540004	Tumor	0.7
CPT0167860004	Tumor	0.7
CPT0218690004	Tumor	0.6
CPT0168270003	Tumor	0.6
CPT0168590003	Tumor	0.6
CPT0190360004	Tumor	0.5
CPT0205570003	Tumor	0.5
CPT0093510003	Tumor	0.5
CPT0125220003	Tumor	0.5
CPT0167970003	Tumor	0.4
CPT0162100003	Tumor	0.3
CPT0206000004	Tumor	0.3
CPT0071100003	Tumor	0.3
CPT0127480003	Tumor	0.3
CPT0167640003	Tumor	0.3
CPT0196850003	Tumor	0.3
CPT0162020003	Tumor	0.3
CPT0168830003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0171580008	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0161730003	Tumor	0.1
CPT0219080004	Tumor	0.0
CPT0205890003	Tumor	0.0
CPT0168080003	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0078580003	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0206450003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0167750004	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0168380003	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0002410011	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0093360003	Tumor	-0.1
CPT0093550003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0206880003	Tumor	-0.2
CPT0217000004	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0218330004	Tumor	-0.2
CPT0206560003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0217060003	Tumor	-0.2
CPT0205780003	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0225730003	Tumor	-0.3
CPT0208980003	Tumor	-0.3
CPT0168720003	Tumor	-0.3
CPT0087570003	Tumor	-0.3
CPT0204410003	Normal	-0.3
CPT0218770003	Tumor	-0.3
CPT0167530003	Tumor	-0.3
CPT0207090003	Tumor	-0.4
CPT0217710008	Tumor	-0.4
CPT0087680003	Tumor	-0.4
CPT0125570003	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0189460003	Tumor	-0.4
CPT0064650003	Tumor	-0.4
CPT0182550003	Tumor	-0.4
CPT0206110003	Tumor	-0.5
CPT0093590003	Tumor	-0.5
CPT0204340003	Normal	-0.5
CPT0218830004	Tumor	-0.6
CPT0216920008	Tumor	-0.6
CPT0218890004	Tumor	-0.6
CPT0089150003	Tumor	-0.6
CPT0204370003	Normal	-0.6
CPT0217100003	Tumor	-0.6
CPT0204380003	Normal	-0.6
CPT0104330003	Tumor	-0.7
CPT0224390004	Tumor	-0.7
CPT0104220003	Tumor	-0.7
CPT0189750004	Tumor	-0.7
CPT0204330003	Normal	-0.8
CPT0189250003	Tumor	-0.8
CPT0204350003	Normal	-0.8
CPT0186100003	Tumor	-0.8
CPT0225760003	Tumor	-0.8
CPT0175060003	Tumor	-0.9
CPT0087730003	Tumor	-0.9
CPT0217190003	Tumor	-0.9
CPT0218670003	Tumor	-0.9
CPT0204420003	Normal	-0.9
CPT0206780003	Tumor	-0.9
CPT0224330003	Tumor	-1.0
CPT0182500003	Tumor	-1.1
CPT0204400003	Normal	-1.1
CPT0204390003	Normal	-1.1
CPT0206330003	Tumor	-1.2
CPT0217880003	Tumor	-1.2
CPT0125510003	Tumor	-1.2
CPT0162140003	Tumor	-1.2
CPT0207030003	Tumor	-1.3
CPT0182580003	Tumor	-1.5
CPT0190240004	Tumor	-2.0
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis